|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.83 USD | +1.93% |
|
+1.60% | +25.24% |
| Capitalization | 2.6B 2.21B 2.05B 1.93B 3.59B 238B 3.8B 23.44B 9.29B 112B 9.74B 9.54B 411B | P/E ratio 2025 * |
-35.4x | P/E ratio 2026 * | -124x |
|---|---|---|---|---|---|
| Enterprise value | 3.04B 2.59B 2.4B 2.25B 4.19B 278B 4.45B 27.43B 10.87B 132B 11.4B 11.17B 481B | EV / Sales 2025 * |
0.53x | EV / Sales 2026 * | 0.51x |
| Free-Float |
97.42% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: RXO, Inc.
| 1 day | +1.93% | ||
| 1 week | +1.60% | ||
| Current month | +25.24% | ||
| 1 month | +20.66% | ||
| 3 months | -9.65% | ||
| 6 months | -4.47% | ||
| Current year | +25.24% |
| 1 week | 14.35 |  | 16.04 |
| 1 month | 12.33 | | 16.04 |
| Current year | 12.49 | | 16.04 |
| 1 year | 10.42 | | 26.92 |
| 3 years | 10.42 | | 32.82 |
| 5 years | 10.42 | | 32.82 |
| 10 years | 10.42 | | 32.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Wilkerson
CEO | Chief Executive Officer | 42 | 16/10/2022 |
James Harris
DFI | Director of Finance/CFO | 64 | - |
Yoav Amiel
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Wilkerson
CHM | Chairman | 42 | 30/04/2025 |
Adrian Kingshott
BRD | Director/Board Member | 66 | 31/10/2022 |
Mary Kissel
BRD | Director/Board Member | 49 | 31/10/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.93% | +1.60% | -38.71% | -6.39% | 2.6B | |
| -0.08% | +0.02% | -5.58% | +12.45% | 37.27B | |
| +0.49% | +2.04% | +20.48% | +11.44% | 19.93B | |
| +0.25% | +0.44% | -27.31% | +44.76% | 9.58B | |
| +0.29% | -1.64% | -20.64% | +6.67% | 9.18B | |
| +0.50% | +1.18% | -10.99% | -6.23% | 5.42B | |
| +0.05% | +2.87% | +78.14% | +207.63% | 2.72B | |
| +2.12% | +3.31% | -7.43% | -23.19% | 2.07B | |
| -0.16% | 0.00% | +76.56% | +137.38% | 1.84B | |
| +1.12% | +0.48% | -7.45% | +32.22% | 1.85B | |
| Average | +0.65% | +1.22% | +5.71% | +41.67% | 9.25B | |
| Weighted average by Cap. | +0.28% | +0.67% | -0.94% | +21.20% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.76B 4.91B 4.56B 4.27B 7.95B 528B 8.43B 52.02B 20.61B 249B 21.62B 21.17B 913B | 5.95B 5.07B 4.7B 4.41B 8.21B 545B 8.71B 53.71B 21.28B 258B 22.32B 21.86B 942B |
| Net income | -75.25M -64.05M -59.48M -55.77M -104M -6.89B -110M -679M -269M -3.26B -282M -276M -11.91B | -21.13M -17.98M -16.7M -15.66M -29.16M -1.94B -30.92M -191M -75.57M -914M -79.24M -77.62M -3.35B |
| Net Debt | 442M 376M 349M 328M 610M 40.48B 647M 3.99B 1.58B 19.12B 1.66B 1.62B 69.97B | 448M 381M 354M 332M 618M 41.01B 655M 4.04B 1.6B 19.37B 1.68B 1.64B 70.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/01/26 | 15.83 $ | +1.93% | 997,172 |
| 21/01/26 | 15.53 $ | +6.08% | 1,166,109 |
| 20/01/26 | 14.64 $ | -2.33% | 1,393,284 |
| 16/01/26 | 14.99 $ | -3.79% | 1,255,169 |
| 15/01/26 | 15.58 $ | +2.43% | 1,537,351 |
Delayed Quote Nyse, January 22, 2026 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RXO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition